In a financial risk model analysis of 41 Gavi-eligible countries, the burden of Catastrophic Health Costs (CHC) and Medical Impoverishment (MI) would be greatest in the lowest income populations. With expanded vaccine coverage, the share of prevented cases of measles, pneumococcal disease, and rotavirus, in relation to the total number of cases prevented, would be larger in the lowest income populations thereby providing a larger financial risk protection (FRP) to these populations.
Full Citation:
Riumallo-Herl, C., Chang, A.Y., Clark, S., et al.. 2018. Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus, and pneumococcal vaccines in low-income and middle-income countries: a modeling study. British Journal of Medicine Global Health. 3:e000612.
Title of Article: Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus, and pneumococcal vaccines in low-income and middle-income countries: a modeling study
Author(s): Riumallo-Herl, C., Chang, A.Y., Clark, S., et al.
Publication Year: 2018
Publication Name: British Journal of Medicine Global Health
Publication Volume: 3:e000612
Publication Source URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898318/
DOI (Digital Object Identifier): http://dx.doi.org/10.1136/bmjgh-2017-000613
Topics: Economics & Return on Investment
Disease Vaccines: Measles | Pneumococcal disease/PCV/PPSV | Rotavirus
Immunization Terms: Impoverishment | Wealth inequity
Countries: Global